MDCX Medicus Pharma Ltd.

NASDAQ
$0.15

Medicus Pharma Ltd. (MDCX) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.17 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -54.1% since its last earnings release on August 12, 2026.

Medicus Pharma Missed Consensus Estimates
Wednesday, August 12, 2026 · 6:00 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 6:00 PM ET
Earnings Whisper
-
vs ($0.17)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $0.18

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Medicus Pharma Ltd.

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.